ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market
Holding ALXO?
Track your performance easily

ALX Oncology Holdings (ALXO) Financial Statements

349 Followers

ALX Oncology Holdings Financial Overview

ALX Oncology Holdings's market cap is currently ―. The company's EPS TTM is $-3.637; its P/E ratio is -0.40; ALX Oncology Holdings is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.71. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -30.26M$ -38.97M$ -35.15M$ -45.06M$ -50.60M
EBITDA$ -29.51M$ -36.73M$ -34.94M$ -44.85M$ -50.39M
Net Income Common Stockholders$ -30.71M$ -39.40M$ -35.58M$ -45.47M$ -50.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 148.57M$ 156.72M$ 157.44M$ 182.74M$ 190.01M
Total Assets$ 185.72M$ 214.62M$ 212.65M$ 242.55M$ 220.11M
Total Debt$ 9.84M$ 9.77M$ 9.70M$ 9.64M$ 9.57M
Net Debt$ -138.74M$ -146.95M$ -147.73M$ -173.10M$ -180.43M
Total Liabilities$ 48.91M$ 55.30M$ 48.45M$ 52.84M$ 51.35M
Stockholders Equity$ 136.81M$ 159.32M$ 164.19M$ 189.71M$ 168.75M
Cash Flow-
Free Cash Flow$ -25.52M$ -26.66M$ -38.07M$ -39.83M$ -29.86M
Operating Cash Flow$ -25.38M$ -26.57M$ -37.92M$ -39.68M$ -31.16M
Investing Cash Flow$ 25.69M$ 907.00K$ 26.47M$ -16.67M$ 12.81M
Financing Cash Flow$ 251.00K$ 27.15M$ 3.09M$ 59.17M$ -111.00K
Currency in USD

ALX Oncology Holdings Earnings and Revenue History

ALX Oncology Holdings Debt to Assets

ALX Oncology Holdings Cash Flow

ALX Oncology Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis